ADVA
11.5.2022 09:02:09 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Westfalen Weser Netz has deployed its ALM fiber monitoring technology for precise, real-time insight into its regional metro network. The solution gives the municipal utility provider complete infrastructure assurance. Now it can instantly detect and rapidly repair fiber breaks with minimal disruption. The ADVA ALM enables Westfalen Weser Netz to dramatically shorten repair cycles and enhance network performance. It also means far fewer truck rolls and significant savings on fuel cost. The technology integrated seamlessly into Westfalen Weser Netz’s cableScout® management software provided by ADVA’s partner JO Software Engineering GmbH.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005843/en/
“The ADVA ALM is helping us ensure excellent network availability while also reducing maintenance effort and expense. It gives our repair teams the power to remotely measure attenuation and quickly locate any degradation in our fiber plant. They can then take action straightaway to resolve problems,” said Stefan Kenneweg, consultant at Westfalen Weser Netz. “Combining the ADVA ALM assurance solution with our cableScout® management software is like turning on the lights right across our network. Now there are no more blind spots. That means no more wasted hours on false alarms and no nasty surprises for our customers.”
The ADVA ALM is now delivering passive, in-service monitoring of Westfalen Weser Netz’s fiber links. The simple, plug-and-play device offers several key advantages for utility network assurance. Its fanless operation and compact, low-energy design reduce opex and environmental impact. It’s also a highly robust solution ready to be installed in almost any location. Built on standardized, open management interfaces, the ADVA ALM is fully interoperable with Westfalen Weser Netz’s existing cableScout® software. This provides a geographic information system (GIS) to quickly and easily locate failures.
“Our ALM fiber monitoring platform is already bringing major benefits to Westfalen Weser Netz and its customers, helping the company reduce truck rolls and maximize resource efficiency. There really is no technology that has this much impact with such little cost and effort,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “When it comes to providing homes and businesses with safe, efficient and sustainable electricity, gas and water, the reliability of the data transport network is crucial. Now that Westfalen Weser Netz has total visibility and control of its fiber infrastructure, it can avoid outages and introduce new services with confidence.”
“Our cableScout® platform combined with the ADVA ALM solution for in-service monitoring provides Westfalen Weser Netz with continual access to a detailed layout of its network. Its team now has comprehensive understanding of the complete fiber architecture, enabling efficient end-to-end planning, management and troubleshooting,” said Ralph Kosztovits, managing partner at JO Software Engineering GmbH. “ADVA is a company that shares our commitment to sustainable growth and creating new opportunities through innovation. Our close alliance offers major benefits for network operators like Westfalen Weser Netz who are committed to empowering customers to achieve more and enhancing end user experience.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005843/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom